Anavex Life Sciences Corp (AVXL)

[drv17]

blu - regarding Australia's Anavex A2-73 trial
It was also mentioned in The Alfred Group Annual Report 2015-16 a couple of times in the report. Specifically in the Caufield Unit portion on page 27 which was a continuation of the Research report starting on page 26 (potions copied here)



26 Annual Report 2015-16

Research through partnership


Alfred Health 27
(Section excerpted here)

Alzheimer’s drug trial success

Early research results of Anavex 2-73, a drug which aims to address the symptoms of dementia, are positive. Trials at Caulfield Hospital are using Anavex, which, unlike current medications, is the only drug designed to both relieve symptoms and slow the disease’s progression. The first phase of the trial began in December 2014 and the next steps will involve further research with a larger group of participants in 2017

Anavex was mentioned a few other times in the long report for the Alfred group